GlucoTrack (NASDAQ:GCTK) Shares to Reverse Split on Monday, August 31st

GlucoTrack, Inc. (NASDAQ:GCTK) shares are going to reverse split on Monday, August 31st. The 1-15 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, August 30th.

GlucoTrack Stock Down 10.9%

NASDAQ GCTK traded down $0.03 during trading hours on Thursday, hitting $0.29. The company had a trading volume of 1,670,509 shares, compared to its average volume of 24,427,032. The firm’s 50 day moving average is $0.39 and its 200 day moving average is $0.75. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.46 and a quick ratio of 0.46. GlucoTrack has a fifty-two week low of $0.25 and a fifty-two week high of $14.14. The company has a market capitalization of $2.21 million, a price-to-earnings ratio of -0.03 and a beta of 0.70.

GlucoTrack (NASDAQ:GCTK) last released its quarterly earnings data on Friday, August 14th. The company reported $0.76 EPS for the quarter.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on GCTK shares. Wall Street Zen raised GlucoTrack from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Hedge Funds Weigh In On GlucoTrack

A number of institutional investors and hedge funds have recently added to or reduced their stakes in GCTK. Ikarian Capital LLC purchased a new position in GlucoTrack in the fourth quarter valued at about $177,000. Boothbay Fund Management LLC purchased a new stake in GlucoTrack during the 4th quarter worth approximately $52,000. Finally, Bank of America Corp DE increased its holdings in GlucoTrack by 102,125.0% during the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares during the last quarter. 10.92% of the stock is owned by hedge funds and other institutional investors.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.